Common Gynecologic Issues in Patients Post-Kidney Transplantation
Abstract
Advances in kidney transplantation have transformed survival and quality of life for women with end-stage renal disease, necessitating a focus on long-term health care for this population. Female kidney transplant recipients (KTR) experience a unique spectrum of gynecologic issues shaped by persistent hormonal dysregulation, lifelong immunosuppression, and complex surgical history. These factors contribute to increased rates of abnormal uterine bleeding, endometrial hyperplasia, and early menopause. Furthermore, common conditions such as fibroids, endometriosis, pelvic pain, and pelvic organ prolapse have unique challenges in diagnosis and management. Preventative care also requires attention, with unique cancer screening recommendations, nuanced contraception and hormonal therapy decisions, and consideration for osteoporosis prevention. Current evidence in many of these areas remains limited, highlighting the need for further research. Overall, multidisciplinary collaboration among transplant specialists, gynecologists, and primary care providers is essential to optimize reproductive health across the lifespan and optimize transplant outcomes in this growing population. Social Media: Kidney transplant recipients experience a unique spectrum of gynecologic issues and require special considerations during diagnosis and treatment.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.